For individuals diagnosed with hormone receptor-positive breast cancer, one common medication used in treatment is letrozole. Letrozole is an aromatase inhibitor that works by decreasing the amount of estrogen produced in the body, thereby slowing or stopping the growth of cancer cells that need estrogen to grow.
During a letrozole course, patients take a daily oral dose of the medication for a specified period. This treatment approach can help reduce the risk of cancer recurrence and improve overall survival rates. Letrozole has been shown to be particularly effective in postmenopausal women with hormone receptor-positive breast cancer.
Some of the key benefits of a letrozole course in breast cancer treatment include:
It is important for patients to discuss the potential benefits and risks of a letrozole course with their healthcare provider to determine if this treatment option is right for them. By following a prescribed letrozole course, individuals with hormone receptor-positive breast cancer may experience improved outcomes and quality of life.